Corrigendum

Código QR

Corrigendum

Wang XJ, Wong SH, Givergis R, Chynn EW. Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK. Clin Ophthalmol. 2011;5:1451-1457.On page 1456 the Acknowledgment section details were incomplet...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Chynn EW, Givergis R, Wong SH, Wang XJ
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/9e8cc5f836c543cd99d613e62ca1fa01
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK
por: Wang XJ, et al.
Publicado: (2011)

Corrigendum
por: Schneider EW, et al.
Publicado: (2011)

Corrigendum
por: Teus MA, et al.
Publicado: (2011)

Corrigendum
por: Nelson DA, et al.
Publicado: (2011)

Corrigendum
por: Mizoguchi T, et al.
Publicado: (2012)

Corrigendum
por: Brief G, et al.
Publicado: (2012)

Corrigendum
por: Sakai T, et al.
Publicado: (2012)

Short wave–automated perimetry (SWAP) versus optical coherence tomography in early detection of glaucoma [Corrigendum]
por: Zaky AG, et al.
Publicado: (2018)

Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a review
por: Schneider EW, et al.
Publicado: (2011)

Relationships Between Retinal Break Locations And The Shapes Of The Detachments [Corrigendum]
por: Yoshida I, et al.
Publicado: (2019)

De novo ocular hypertension after Descemet stripping endothelial keratoplasty: comparative 3-year incidence, risk factors, and outcomes
por: Chan EW, et al.
Publicado: (2013)

Intracameral phenylephrine and ketorolac injection (OMS302) for maintenance of intraoperative pupil diameter and reduction of postoperative pain in intraocular lens replacement with phacoemulsification [Corrigendum]
por: Lindstrom RL, et al.
Publicado: (2015)

Corrigendum: Softec HD hydrophilic acrylic intraocular lens: biocompatibility and precision
por: Espandar L, et al.
Publicado: (2011)

Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction [Corrigendum]
por: Muñoz Negrete FJ, et al.
Publicado: (2017)

Challenges to detect glaucomatous visual field loss with pupil perimetry [Corrigendum]
por: Asakawa K, et al.
Publicado: (2019)

Risk factors for requirement of filtration surgery after vitrectomy in patients with proliferative diabetic retinopathy [Corrigendum]
por: Sakamoto M, et al.
Publicado: (2018)

Comparison of cumulative dissipated energy between the Infiniti and Centurion phacoemulsification systems [Corrigendum]
por: Chen M, et al.
Publicado: (2015)

Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]
por: Korol AR, et al.
Publicado: (2017)

Bimatoprost ophthalmic solution 0.03% lowered intraocularpressure of normal-tension glaucoma with minimal adverse events [Corrigendum]
por: Tsumura T, et al.
Publicado: (2013)

Outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic patient population [Corrigendum]
por: Gallardo MJ, et al.
Publicado: (2016)

Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration [Corrigendum]
por: Dervenis N, et al.
Publicado: (2016)

Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents [Corrigendum]
por: Pillunat LE, et al.
Publicado: (2018)

Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events. [Corrigendum]
por: Tsumura T, et al.
Publicado: (2013)

Success of patient training in improving proficiency of eyedrop administration among various ophthalmic patient populations [Corrigendum]
por: Feng A, et al.
Publicado: (2017)

Corrigendum: Efficacy and safety of travoprost alone or in combination with other agents for glaucoma and ocular hypertension: patient considerations
por: Suzuki CLB, et al.
Publicado: (2010)

Corrigendum - Intraocular pressure changes following the use of silicone oil or Densiron 68 as endotamponade in pars plana vitrectomy
por: Romano MR, et al.
Publicado: (2010)

Impact of conjunctival autograft on pterygium treatment: evaluation of related symptoms and patients’ satisfaction after surgery [Corrigendum]
por: Wanzeler AC, et al.
Publicado: (2018)

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum]
por: Tsumura T, et al.
Publicado: (2015)

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum]
por: Tsumura T, et al.
Publicado: (2015)

Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications [Corrigendum]
por: Shen J, et al.
Publicado: (2018)

Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion [Corrigendum]
por: Tagami M, et al.
Publicado: (2017)

Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]
por: Nudleman E, et al.
Publicado: (2017)

Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]
por: Nichols KK, et al.
Publicado: (2018)

Clinical outcomes of 4-point scleral fixated 1-piece hydrophobic acrylic equiconvex intraocular lens using polytetrafluoroethylene suture [Corrigendum]
por: Patel NA, et al.
Publicado: (2019)

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]
por: Tauber J, et al.
Publicado: (2019)

A Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]
por: Tauber J, et al.
Publicado: (2018)

Delayed manifestation of bilateral scleral thinning after I-BRITE® procedure and review of literature for cosmetic eye-whitening procedures [Corrigendum]
por: Moshirfar M, et al.
Publicado: (2016)

A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum]
por: Singh RP, et al.
Publicado: (2017)

Spectral domain optical coherence tomography imaging in optic disk pit associated with outer retinal dehiscence
por: Wong CW, et al.
Publicado: (2014)

Retrospective analysis of patients self-referred to comprehensive ophthalmology seeking second opinions
por: Gologorsky D, et al.
Publicado: (2013)